Oropharyngeal Gonorrhea in Absence of Urogenital Gonorrhea in Sexual Network of Male and Female Participants, Australia, 2018 [PDF]
Emerging Infectious Diseases, 2019 We describe a sexual network consisting of 1 nonbinary-gendered participant and 2 male and 4 female participants in Australia, 2018. Six of 7 participants had oropharyngeal gonorrhea in the absence of urogenital gonorrhea. This observation supports a new
Vincent J. Cornelisse +4 more
doaj +3 more sources
EPIDEMIOLOGICAL TRENDS OF ANTIBIOTIC-RESISTANT NEISSERIA GONORRHEA IN THE EU/EEA/EUROPEAN REGION: A SYSTEMATIC REVIEW [PDF]
Health Problems of Civilization, 2023 Neisseria gonorrhea is becoming more resistant to available antibiotic treatments. The growing antibiotic resistance of Neisseria gonorrhea in clinical isolates has been observed by different national surveillance systems around the globe and is ...
Gurkeerat Gill
doaj +2 more sources
Optimal control dynamics of Gonorrhea in a structured population
Heliyon, 2023 Gonorrhea is a serious global health problem due to its high incidence, with approximately 82.4 million new cases in 2020. To evaluate the consequences of targeted dynamic control of gonorrhea infection transmission, a model for gonorrhea with optimal ...
Gui-Quan Sun, Joshua Kiddy K Asamoah
exaly +3 more sources
Adult gonorrhea, chlamydia and syphilis prevalence, incidence, treatment and syndromic case reporting in South Africa: Estimates using the Spectrum-STI model, 1990-2017 [PDF]
PLoS ONE, 2018 OBJECTIVES:To estimate trends in prevalence and incidence of syphilis, gonorrhea and chlamydia in adult men and women in South Africa. METHODS:The Spectrum-STI tool estimated trends in prevalence and incidence of active syphilis, gonorrhea and chlamydia,
Leigh F Johnson +2 more
exaly +2 more sources
Measuring the health benefits and costs of antimicrobial-resistant gonorrhea surveillance in the United States: an agent-based model and cost-effectiveness analysis [PDF]
The Lancet Regional Health. AmericasSummary: Background: Antimicrobial resistant (AMR) gonorrhea poses an increasing threat to public health, yet evidence on the cost-effectiveness of surveillance systems that inform treatment policy is lacking.
Marcy S. Ekanayake-Weber +10 more
doaj +2 more sources
Mathematical analysis of a model for Chlamydia and Gonorrhea codynamics with optimal control
Results in Physics, 2021 A model for Chlamydia trachomatis (CT) and Gonorrhea codynamics, with optimal control analysis is studied and analyzed to assess the impact of targetted treatment for each of the diseases on their co-infections in a population.
Andrew Omame, Chibueze Onyenegecha
exaly +3 more sources
Socioeconomic factors associated with chlamydia and gonorrhea positivity in the United States, 2022–2024 [PDF]
BMC Public HealthBackground Socioeconomic factors (SEF) can be associated with health outcomes. Understanding the relationships among SEF, demographics, and sexually transmitted infection (STI) positivity can help identify areas to improve STI prevention and care with ...
Larry He +3 more
doaj +2 more sources
Analysis and prediction of the incidence and prevalence trends of gonorrhea in China
Human Vaccines and Immunotherapeutics, 2023 To understand the epidemiological trend of gonorrhea in China from 2004 to 2021, predict the prevalence of the disease, and provide basic theory and data support for monitoring and managing gonorrhea.
Yongzhang Zhu, Yufeng Yao
exaly +2 more sources
Clinical Practice and Cases in Emergency Medicine, 2020 Sexually transmitted infections have risen sharply over the last decade in the United States. The incidence of gonorrhea has risen to 172 reported cases per 100,000 people over the past year.
Janelle Estrada +2 more
doaj +2 more sources
Vaccines, 2023 Globally, >80 million new gonorrhea infections occur annually. Here, we assessed barriers to and influences on participation in a gonorrhea clinical trial and the impact of educational intervention. The survey was fielded in the US in March 2022.
Michael Penlington +2 more
doaj +1 more source